BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19909981)

  • 1. Gene therapy using lactoferrin-modified nanoparticles in a rotenone-induced chronic Parkinson model.
    Huang R; Ke W; Liu Y; Wu D; Feng L; Jiang C; Pei Y
    J Neurol Sci; 2010 Mar; 290(1-2):123-30. PubMed ID: 19909981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotection in a 6-hydroxydopamine-lesioned Parkinson model using lactoferrin-modified nanoparticles.
    Huang R; Han L; Li J; Ren F; Ke W; Jiang C; Pei Y
    J Gene Med; 2009 Sep; 11(9):754-63. PubMed ID: 19554623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous glial-derived neurotrophic factor gene therapy of experimental Parkinson's disease with Trojan horse liposomes and a tyrosine hydroxylase promoter.
    Xia CF; Boado RJ; Zhang Y; Chu C; Pardridge WM
    J Gene Med; 2008 Mar; 10(3):306-15. PubMed ID: 18085726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactoferrin-modified nanoparticles could mediate efficient gene delivery to the brain in vivo.
    Huang R; Ke W; Han L; Liu Y; Shao K; Jiang C; Pei Y
    Brain Res Bull; 2010 Apr; 81(6):600-4. PubMed ID: 20026388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.
    Connor B; Kozlowski DA; Schallert T; Tillerson JL; Davidson BL; Bohn MC
    Gene Ther; 1999 Dec; 6(12):1936-51. PubMed ID: 10637445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
    Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
    Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pitx3-transfected astrocytes secrete brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor and protect dopamine neurons in mesencephalon cultures.
    Yang D; Peng C; Li X; Fan X; Li L; Ming M; Chen S; Le W
    J Neurosci Res; 2008 Nov; 86(15):3393-400. PubMed ID: 18646205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.
    Winkler C; Georgievska B; Carlsson T; Lacar B; Kirik D
    Neuroscience; 2006 Aug; 141(1):521-31. PubMed ID: 16697115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease.
    Mandel RJ; Snyder RO; Leff SE
    Exp Neurol; 1999 Nov; 160(1):205-14. PubMed ID: 10630205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrastriatal GDNF gene transfer by inducible lentivirus vectors protects dopaminergic neurons in a rat model of parkinsonism.
    Chen SS; Yang C; Hao F; Li C; Lu T; Zhao LR; Duan WM
    Exp Neurol; 2014 Nov; 261():87-96. PubMed ID: 24997241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant adeno-associated viral vectors bring gene therapy for Parkinson's disease closer to reality.
    Muramatsu S; Wang L; Ikeguchi K; Fujimoto K; Nakano I; Ozawa K
    J Neurol; 2002 Sep; 249 Suppl 2():II36-40. PubMed ID: 12375062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated transduction with human glial cell line-derived neurotrophic factor gene prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopamine depletion in striatum of mouse brain.
    Kojima H; Abiru Y; Sakajiri K; Watabe K; Ohishi N; Takamori M; Hatanaka H; Yagi K
    Biochem Biophys Res Commun; 1997 Sep; 238(2):569-73. PubMed ID: 9299553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral alterations in rotenone model of Parkinson's disease: attenuation by co-treatment of centrophenoxine.
    Nehru B; Verma R; Khanna P; Sharma SK
    Brain Res; 2008 Mar; 1201():122-7. PubMed ID: 18308296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates.
    Behrstock S; Ebert A; McHugh J; Vosberg S; Moore J; Schneider B; Capowski E; Hei D; Kordower J; Aebischer P; Svendsen CN
    Gene Ther; 2006 Mar; 13(5):379-88. PubMed ID: 16355116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled delivery of glial cell line-derived neurotrophic factor by a single tetracycline-inducible AAV vector.
    Chtarto A; Yang X; Bockstael O; Melas C; Blum D; Lehtonen E; Abeloos L; Jaspar JM; Levivier M; Brotchi J; Velu T; Tenenbaum L
    Exp Neurol; 2007 Mar; 204(1):387-99. PubMed ID: 17223106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production.
    Sajadi A; Bauer M; Thöny B; Aebischer P
    J Neurochem; 2005 Jun; 93(6):1482-6. PubMed ID: 15935064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoviral gene transfer of BDNF and GDNF synergistically prevent motoneuron loss in the nucleus ambiguus.
    Moro K; Shiotani A; Watabe K; Takeda Y; Saito K; Mori Y; Ogawa K
    Brain Res; 2006 Mar; 1076(1):1-8. PubMed ID: 16473328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal gene delivery of glial cell line-derived neurotrophic factor ameliorated paraplegia in rats after spinal ischemia.
    Chou AK; Yang LC; Wu PC; Wong WT; Liu GS; Chen JT; Howng SL; Tai MH
    Brain Res Mol Brain Res; 2005 Feb; 133(2):198-207. PubMed ID: 15710236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible neurochemical changes mediated by delayed intrastriatal glial cell line-derived neurotrophic factor gene delivery in a partial Parkinson's disease rat model.
    Yang X; Mertens B; Lehtonen E; Vercammen L; Bockstael O; Chtarto A; Levivier M; Brotchi J; Michotte Y; Baekelandt V; Sarre S; Tenenbaum L
    J Gene Med; 2009 Oct; 11(10):899-912. PubMed ID: 19639608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.